Regulatory compliance is a critical aspect of pharmaceutical product lifecycle management. When making post-approval changes in topical formulations, selecting the appropriate FDA submission pathway—CBE-30 (Changes Being Effected in 30 Days) or PAS (Prior Approval Supplement)—ensures compliance while maintaining business continuity. Understanding when to file CBE-30 vs. PAS can significantly impact timelines, regulatory approvals, and market…
Formulating effective topical products is a complex process that requires balancing efficacy, stability, and patient compliance. Here are some common challenges and practical solutions: Poor Drug Penetration Instability of Active Ingredients Phase Separation in Emulsions Grittiness or Texture Issues Preservative System Failure Inconsistent Spreadability & Feel Successful topical formulations require a deep understanding of formulation…
In the evolving pharmaceutical landscape, Quality by Design (QbD) has transformed the Chemistry, Manufacturing, and Controls (CMC) framework, shifting the focus from mere compliance to science- and risk-based drug development. Why QbD Matters in CMC? Traditionally, regulatory submissions relied on empirical data with limited flexibility. QbD, however, ensures a deep understanding of product and process…
In topical pharmaceutical development, achieving batch-to-batch consistency, therapeutic efficacy, and regulatory compliance requires a Quality by Design (QbD) framework. A well-defined design space based on Critical Material Attributes (CMAs), Critical Process Parameters (CPPs), and Critical Quality Attributes (CQAs) ensures an optimized, scalable, and reproducible formulation. Identifying CMAs in Topical Formulations API Attributes: Excipient Functionality: Defining…
Changes in equipment used for manufacturing a product can have different implications depending on the market. Regulatory authorities assess these changes based on their potential impact on product quality, safety, and efficacy. Below is a comparative view of how major markets handle equipment changes: USFDA Risk-Based Approach: Major Change (Prior Approval Supplement – PAS): If…
Transferring a formulation to a new site requires careful planning to ensure product consistency, regulatory compliance, and quality assurance. Technical Considerations Quality & Regulatory Considerations Conclusion A well-managed site transfer ensures product integrity, regulatory approval, and seamless market continuity. Read also: Resource Person: Moinuddin syed. Ph.D, PMP
